Lithuanian University of Health Sciences
- Address
- Eivenių g. 2, LT-50161 Kaunas, Lithuania
Lithuanian University of Health Sciences - Advanced Respiratory and Renal Disease Research
The Lithuanian University of Health Sciences is a distinguished clinical research institution with specialized expertise in evaluating novel therapeutic interventions for complex pulmonary and renal disorders. The center demonstrates particular strength in conducting early-phase and extension studies that assess both safety and efficacy of innovative drug delivery systems and targeted biological therapies.
- Pulmonary Arterial Hypertension (PAH) and long-term evaluation of inhaled therapeutics
- Rare kidney diseases including C3 Glomerulopathy and Immune Complex-Mediated Glomerulonephritis
- Cystic Fibrosis with focus on inhalation-based drug delivery systems
The research center's portfolio reflects a commitment to advancing treatment options for patients with rare and life-threatening conditions. Their involvement in open-label extension studies and maximum tolerated dose (MTD) evaluations demonstrates capability in comprehensive long-term safety monitoring and pharmacokinetic assessments. The center's expertise spans inhalation therapy research for respiratory conditions and intravenous biological therapies for complex immune-mediated renal diseases, positioning them as a valuable partner in multi-center international clinical trial networks focused on orphan diseases and unmet medical needs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Splisense Ltd.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lithuanian University of Health Sciences
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of OMS906 Safety and Efficacy in Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis | Omeros Corp. | Phase II | Not Recruiting | Jan 2024 | Apr 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Oms906 | 1 | Unknown | 2024-01-29 | 2024-01-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.